Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Emily Thrash"'
Autor:
Hiro Tatetsu, Miho Watanabe, Jun Liu, Kenji Tokunaga, Eisaku Iwanaga, Yoshihiro Komohara, Emily Thrash, Mahmoud A. Bassal, Masao Matsuoka, Daniel G. Tenen, Li Chai
Publikováno v:
Clinical and Translational Medicine, Vol 13, Iss 8, Pp n/a-n/a (2023)
Externí odkaz:
https://doaj.org/article/099f8f72f1da49b2a589a82379113b48
Autor:
Hiro Tatetsu, Miho Watanabe, Jun Liu, Kenji Tokunaga, Eisaku Iwanaga, Yoshihiro Komohara, Emily Thrash, Matsuoka Masao, Daniel G. Tenen, Li Chai
Myelodysplastic syndrome (MDS) is a group of heterogeneous diseases characterized by cytologic dysplasia and cytopenias resulting from ineffective hematopoiesis. Oncofetal protein SALL4 is a known oncogene in MDS and its baseline expression level ser
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::507016bb21bb01e780992ae6248866e6
https://doi.org/10.1101/2022.12.05.518121
https://doi.org/10.1101/2022.12.05.518121
Autor:
Deepti, Gadi, Alec, Griffith, Svitlana, Tyekucheva, Zixu, Wang, Vanessa, Rai, Alexander, Vartanov, Emily, Thrash, Stacey M, Fernandes, Timothy Z, Lehmberg, Brandon, Lee, Stephen P, Martindale, John-Hanson, Machado, Oreofe, Odejide, Philippe, Armand, David C, Fisher, Jon, Arnason, Matthew S, Davids, James A, Lederer, Jennifer R, Brown
Publikováno v:
Leukemia. 36(3)
Several PI3Kδ inhibitors are approved for the therapy of B cell malignancies, but their clinical use has been limited by unpredictable autoimmune toxicity. We have recently reported promising efficacy results in treating chronic lymphocytic leukemia